What does “Epkinly” refer to?
“Epkinly” is a brand name that people often use to refer to epcoritamab (a CD20xCD3 bispecific antibody). Epcoritamab is used for certain types of lymphoma, including diffuse large B-cell lymphoma (DLBCL) after prior treatments, and it is given as an injection. [1]
How is Epkinly (epcoritamab) taken?
Epcoritamab is administered by injection on a dosing schedule that typically starts with lower “step-up” doses and then moves to maintenance dosing. The exact schedule depends on the treatment protocol and your regimen. [1]
What is Epkinly used for?
Epcoritamab is used for specific B-cell lymphomas, including DLBCL in people who have had prior therapies. Indications can vary by country and by treatment line. [1]
What side effects do patients usually ask about?
Because epcoritamab is a bispecific antibody, commonly discussed risks include cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), plus other side effects that can occur with cancer immunotherapies. Your oncology team will screen for risk and may give premedications and monitoring. [1]
How do doctors monitor for CRS and neurotoxicity?
Monitoring is most intensive around the initial doses (especially during step-up dosing) and after dose escalations. Clinicians watch for fever, low blood pressure, breathing problems, confusion, or neurologic symptoms and treat promptly if symptoms occur. [1]
What should you do if you meant something else by “Epkinly”?
If you meant a different medication or brand (spelling varies), tell me:
- the full name on the box or prescription, and
- your country, and
- what condition it was prescribed for.
Then I can match the correct drug and explain it accurately.
---
Sources
[1] https://www.drugs.com/epkinly.html